Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1968 Jun;43(229):358–361. doi: 10.1136/adc.43.229.358

Diazoxide in von Gierke's disease.

O M Rennert, D Mukhopadhyay
PMCID: PMC2019951  PMID: 5240134

Full text

PDF
358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHMORE J., CAHILL G. F., Jr, HASTINGS A. B. Inhibition of glucose-6-phosphatase by hypoglycemic sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):774–777. [PubMed] [Google Scholar]
  2. CORI G. T., CORI C. F. Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem. 1952 Dec;199(2):661–667. [PubMed] [Google Scholar]
  3. DOLLERY C. T., PENTECOST B. L., SAMAAN N. A. Drug-induced diabetes. Lancet. 1962 Oct 13;2(7259):735–737. doi: 10.1016/s0140-6736(62)90567-6. [DOI] [PubMed] [Google Scholar]
  4. DRASH A., WOLFF F. DRUG THERAPY IN LEUCINE-SENSITIVE HYPOGLYCEMIA. Metabolism. 1964 Jun;13:487–492. doi: 10.1016/0026-0495(64)90133-7. [DOI] [PubMed] [Google Scholar]
  5. FREEDLAND R. A., HARPER A. E. Metabolic adaptations in higher animals. III. Quantitative study of dietary factors causing response in liver glucose-6-phosphatase. J Biol Chem. 1958 Jul;233(1):1–4. [PubMed] [Google Scholar]
  6. HUTCHEON D. E., BARTHALMUS K. S. Antihypertensive action of diazoxide. A new benzothiazine with antidiuretic properties. Br Med J. 1962 Jul 21;2(5298):159–161. doi: 10.1136/bmj.2.5298.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. ILLINGWORTH B., CORI G. T. Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen. J Biol Chem. 1952 Dec;199(2):653–660. [PubMed] [Google Scholar]
  8. KOULISCHER N., PICKERING D. E. Glycogen-storage disease: a study on the effect of sodium 1-thyroxine and glucagon. AMA J Dis Child. 1956 Feb;91(2):103–112. doi: 10.1001/archpedi.1956.02060020105001. [DOI] [PubMed] [Google Scholar]
  9. LANGDON R. G., WEAKLEY D. R. The influence of hormonal factors and of diet upon hepatic glucose-6-phosphatase activity. J Biol Chem. 1955 May;214(1):167–174. [PubMed] [Google Scholar]
  10. NEMETH A. M. Glucose-6-phosphatase in the liver of the fetal guinea pig. J Biol Chem. 1954 Jun;208(2):773–776. [PubMed] [Google Scholar]
  11. OKUN R., RUSSELL R. P., WILSON W. R. USE OF DIAZOXIDE WITH TRICHLORMETHIAZIDE FOR HYPERTENSION. Arch Intern Med. 1963 Dec;112:882–888. [PubMed] [Google Scholar]
  12. SEGAL H. L., WASHKO M. E. Studies of liver glucose 6-phosphatase. III. Solubilization and properties of the enzyme from normal and diabetic rats. J Biol Chem. 1959 Aug;234(8):1937–1941. [PubMed] [Google Scholar]
  13. Spergel G., Bleicher S. J. Effects of diazoxide administration on plasma glucose, insulin, and lipids in Von Gierke's disease. Diabetes. 1966 Jun;15(6):406–410. doi: 10.2337/diab.15.6.406. [DOI] [PubMed] [Google Scholar]
  14. TABACHNICK I. I., GULBENKIAN A., SEIDMAN F. THE EFFECT OF A BENZOTHIADIAZINE, DIAZOXIDE, ON CARBOHYDRATE METABOLISM. Diabetes. 1964 Jul-Aug;13:408–418. doi: 10.2337/diab.13.4.408. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES